Kingfa Sci. & Tech. Co., Ltd. (600143.SS)
Guangzhou, CN
Kingfa Science & Technology Co., Ltd. operates on a global scale, focusing its efforts on the innovation, manufacturing, and commercialization of plastic materials. Its comprehensive product portfolio encompasses various advanced polymers, such as plastic compounds, specialized engineering plastics, high-performance chemical substances, environmentally friendly biodegradable plastics, and wood-plastic composites. Additionally, the company provides carbon fibers and other sophisticated composite materials. Beyond these, Kingfa delves into light hydrocarbon and hydrogen energy solutions, alongside developing polymers specifically tailored for medical and healthcare applications. These versatile materials find extensive utility across numerous sectors, including office equipment, the automotive and transport industries, home appliances, building and construction, renewable energy, safety and security, information technology and telecommunications, lighting systems, and consumer electronics. Established in 1993, the company maintains its corporate headquarters in Guangzhou, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -4.57% | -5.16% | -1.40% | -12.56% | -6.93% | -13.46% | +64.81% | +97.09% | -25.04% | +181.36% | +1,480.37% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+7.9% ★ Q1'26: -0.5% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+45.2% ★ Q1'26: +28.3% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+3.0% Q1'26: +6.0% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+4.3% Q1'26: +4.1% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+3.8% Q1'26: +3.4% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-2.7% ★ Q1'26: -2.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×4.84× Q1'26: 11.51× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 3 EPS Ana. |
Dec 2027 3 Rev. Ana. 3 EPS Ana. |
Dec 2028 3 Rev. Ana. 3 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
15.68B
est: 17.00B (-7.8%)
|
17.99B
est: 17.68B (+1.7%)
|
23.14B
est: 22.43B (+3.2%)
|
25.32B
est: 26.31B (-3.8%)
|
29.29B
est: 28.95B (+1.2%)
|
35.06B
est: 35.29B (-0.7%)
|
40.20B
est: 37.54B (+7.1%)
|
40.41B
est: 41.65B (-3.0%)
|
47.94B
est: 50.94B (-5.9%)
|
60.51B
est: 52.93B (+14.3%)
|
65.31B
est: 68.90B (-5.2%)
|
72.33B
69.44B – 76.60B
+5.0% YoY
|
78.00B
74.00B – 81.86B
+7.8% YoY
|
83.33B
82.57B – 84.09B
+6.8% YoY
|
| EBITDA |
1.18B
est: 1.80B (-34.7%)
|
1.35B
est: 1.87B (-27.8%)
|
1.19B
est: 2.38B (-49.8%)
|
1.41B
est: 2.79B (-49.5%)
|
2.74B
est: 3.07B (-10.6%)
|
6.76B
est: 3.74B (+80.9%)
|
4.23B
est: 3.98B (+6.3%)
|
4.02B
est: 4.41B (-8.8%)
|
3.26B
est: 4.30B (-24.2%)
|
3.88B
est: 4.47B (-13.3%)
|
5.57B
est: 5.82B (-4.2%)
|
6.11B
5.86B – 6.47B
+5.0% YoY
|
6.59B
6.25B – 6.91B
+7.8% YoY
|
7.04B
6.97B – 7.10B
+6.8% YoY
|
| EBIT |
878.89M
est: 1.21B (-27.2%)
|
958.85M
est: 1.26B (-23.7%)
|
683.09M
est: 1.59B (-57.1%)
|
856.02M
est: 1.87B (-54.2%)
|
1.88B
est: 2.06B (-8.8%)
|
5.58B
est: 2.51B (+122.5%)
|
2.90B
est: 2.67B (+8.9%)
|
2.58B
est: 2.96B (-12.8%)
|
1.42B
est: 2.44B (-41.9%)
|
1.84B
est: 2.53B (-27.2%)
|
2.82B
est: 3.30B (-14.5%)
|
3.46B
3.32B – 3.66B
+5.0% YoY
|
3.73B
3.54B – 3.92B
+7.8% YoY
|
3.99B
3.95B – 4.02B
+6.8% YoY
|
| Net Income |
711.72M
est: 925.06M (-23.1%)
|
737.29M
est: 819.34M (-10.0%)
|
547.94M
est: 621.11M (-11.8%)
|
624.04M
est: 713.62M (-12.6%)
|
1.24B
est: 1.22B (+2.0%)
|
4.59B
est: 4.21B (+9.0%)
|
1.66B
est: 1.90B (-12.7%)
|
1.99B
est: 1.76B (+13.3%)
|
316.73M
est: 227.44M (+39.3%)
|
824.62M
est: 853.52M (-3.4%)
|
1.15B
est: 1.21B (-4.8%)
|
1.74B
1.64B – 1.87B
+43.7% YoY
|
2.34B
1.98B – 2.72B
+34.6% YoY
|
2.77B
2.35B – 3.48B
+18.3% YoY
|
| SGA |
490.86M
est: 246.31M (+99.3%)
|
599.81M
est: 256.21M (+134.1%)
|
820.03M
est: 324.91M (+152.4%)
|
693.09M
est: 381.26M (+81.8%)
|
707.12M
est: 419.48M (+68.6%)
|
588.76M
est: 511.37M (+15.1%)
|
619.29M
est: 543.88M (+13.9%)
|
580.25M
est: 603.52M (-3.9%)
|
667.98M
est: 977.44M (-31.7%)
|
723.39M
est: 1.02B (-28.8%)
|
2.63B
est: 1.32B (+99.0%)
|
1.39B
1.33B – 1.47B
+5.0% YoY
|
1.50B
1.42B – 1.57B
+7.8% YoY
|
1.60B
1.58B – 1.61B
+6.8% YoY
|
| EPS |
0.28
est: 0.35 (-20.0%)
|
0.29
est: 0.31 (-6.5%)
|
0.20
est: 0.24 (-14.9%)
|
0.23
est: 0.27 (-14.8%)
|
0.47
est: 0.46 (+1.8%)
|
1.78
est: 1.59 (+11.8%)
|
0.65
est: 0.72 (-9.7%)
|
0.77
est: 0.67 (+15.8%)
|
0.12
est: 0.09 (+40.8%)
|
0.31
est: 0.33 (-6.1%)
|
0.45
est: 0.46 (-1.5%)
|
0.67
0.64 – 0.73
+47.2% YoY
|
0.91
0.77 – 1.06
+35.4% YoY
|
1.12
0.91 – 1.35
+22.5% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-28 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-27 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-26 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-25 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-22 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-21 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-20 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-19 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-18 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-15 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-14 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-13 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-12 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-11 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-08 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-07 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-06 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-30 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-29 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-28 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-27 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-24 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | B- | 2/5 | 1/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | B- | 2/5 | 1/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | B- | 2/5 | 1/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | B- | 2/5 | 1/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF ASHS | 0.31% | 113.0K | 0.65% |
| 2 | Xtrackers Harvest CSI A500 UCITS ETF 1D AH50.L | 0.10% | 17.0K | 0.65% |
| 3 | iShares MSCI China A UCITS ETF CNYE.MI | 0.08% | 79.7K | 0.45% |
| 4 | iShares MSCI China A UCITS ETF CNYA.L | 0.08% | 2.42M | 0.40% |
| 5 | iShares MSCI China A ETF CNYA | 0.08% | 181.1K | 0.60% |
| 6 | Xtrackers MSCI China A UCITS ETF 1C XX2D.L | 0.07% | 102.3K | 0.35% |
| 7 | KraneShares ICBCCS S&P China 500 Index UCITS ETF CHIN.L | 0.07% | 55.2K | 0.55% |
| 8 | Amundi MSCI China A UCITS ETF Acc CNAA.L | 0.07% | 96.8K | 0.35% |
| 9 | Invesco MSCI China All Shares Stock Connect UCITS ETF MCHN.L | 0.04% | 42.7K | 0.35% |
| 10 | Amundi MSCI China ESG Selection Extra UCITS ETF Dist LHKG.DE | 0.03% | 143.6K | 0.65% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Bing Zhu | Deputy GM of Marketing | — | female |
| Changan Lei | Chief Financial Officer | — | male |
| Changchang Yuan | Vice Chairman & Executive VP | — | male |
| Di Wu | GM, Marketing GM & Director | — | male |
| He Fen Zheng | Accounting Supervisor | — | — |
| Hesheng Huang | Deputy General Manager | — | male |
| Jian Jun Li | Chief Strategic Scientist | — | male |
| Li Peng | Deputy GM & Director | — | male |
| Yaoshan Dai | Board Secretary | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 600143.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
